Your cart is empty
Continue shopping
Radiesse emerges as a versatile solution, seamlessly blending the benefits of a filler and bio stimulant to address a myriad of cosmetic concerns. Composed of calcium hydroxyapatite (CaHA) microspheres enveloped within a soft gel matrix of sodium carboxymethylcellulose, this innovative formulation yields immediate contouring and lifting effects, courtesy of its highly viscous and elastic gel matrix.
What sets Radiesse apart is its unique ability to not only provide immediate enhancement but also trigger the formation of a network of firm collagen within the skin. This process leads to a reshaping and remodeling of the dermis, culminating in firmer, higher-quality skin. For applications such as skin laxity and cellulite, diluted Radiesse offers an effective solution, administered under the dermis with a cannula to achieve vertical lifting and immediate enhancement, as well as defined contours of the lower face and jawline.
Beyond its immediate aesthetic benefits, Radiesse boasts long-term skin rejuvenation capabilities, owing to its collagen-stimulating properties. As it stimulates the body's collagen production, Radiesse not only lifts the skin and defines facial features but also replenishes lost volume while improving skin texture and elasticity. Its composition, comprising Calcium Hydroxyapatite (CaHA) microspheres suspended in a sodium carboxymethylcellulose (CMC) gel carrier, facilitates volume restoration and facial contouring upon injection. Over time, the CMC gel is gradually absorbed, while the body metabolizes the CaHA microspheres, fostering the generation of natural collagen.
Clinically proven and FDA-approved, Radiesse stands as the first-and-only injectable treatment endorsed for jawline contour improvement. Its efficacy in addressing lower face wrinkles and folds, coupled with its long-term results attributed to collagen and elastin stimulation, positions Radiesse as a frontrunner in the realm of aesthetic enhancements.
Moreover, Radiesse's versatility extends to its application as an injectable implant for deep tissue augmentation, targeting moderate to severe loss of jawline contour in adults over the age of 21. With Radiesse (+) also gaining approval for moderate to severe lower face wrinkles and folds, along with its latest indication for jawline contour improvement, supported by robust Phase 3 studies, this innovative biostimulator continues to redefine aesthetic possibilities.
The efficacy of Radiesse in addressing various cosmetic concerns is underscored by its proven track record, with a significant proportion of trial subjects experiencing improvement in jawline contours as assessed by blinded evaluators. This validation further cements Radiesse's position as a reliable and effective solution for individuals seeking comprehensive facial rejuvenation and enhancement.
